There are several important advantages to RNA therapeutics: (a) target specific, (b) modular with easy-to-switch sequences, (c) predictable in terms of pharmacokinetics and pharmacodynamics, (d) economical in comparison to antibodies or protein drugs since they are synthesized from widely available synthons on an automated synthesizer, and (e) relatively safe, as most of them do not alter the genome.